CTOs on the Move

Brown Physicians

www.brownphysicians.org

 
Brown Physicians, Incorporated (BPI) is a community-based not-for-profit multi-specialty practice group founded and led by faculty affiliated with The Warren Alpert Medical School of Brown University. Our mission is to provide outstanding patient care, exceptional medical education, and groundbreaking advances in research to promote better health for the people of Rhode Island and its surrounding communities. BPI is composed of six foundations, which include Brown Dermatology, Brown Emergency Medicine, Brown Medicine, Brown Neurology, Brown Urology, and University Surgical Associates.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

A10 Clinical Solutions

A10 Clinical Solutions is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elite Research Network

Elite Research Network, LLC is a Mount Pleasant, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

North Valley Health Center

North Valley Health Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. North Valley Health Center is based in Warren, MN. You can find more information on North Valley Health Center at www.nvhc.net

MEDZONE

MEDZONE Inc. is a Montreal, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.